Fresenius Medical Care AG FME.DE

Healthcare · Medical Care Facilities · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$16.58B
Market Cap
$11.91B
Margin of Safety
28.1%
Intrinsic / Market Ratio
1.39

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

19.43B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

14.02B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

16.28B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

16.58B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

16.58B USD

from the sum above

Market Cap

11.91B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

1.39×

the ratio the screener ranks by; Margin of Safety +28.1% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 19.43B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)22.28B USD
−②Net Debt Today10.88B USD
+③Growth Value8.03B USD
=Value19.43B USD

EPV of the Operations (NOPAT over WACC)

22.28B USD

Net debt today

-10.88B USD

Growth Value

+8.03B USD

Value

19.43B USD

①EPV (earnings power value)

22.28B USD

②Net Debt Today

10.88B USD

③Growth Value

8.03B USD

Market value

Market Cap11.91B USD

Today's price times the shares.

Value vs market

Margin of Safety+38.7%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 14.02B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE8.60B USD
+②Equity at Year 15, Today5.42B USD
=Value14.02B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROE on new investment rising to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

8.60B USD

②Equity at Year 15, Today

5.42B USD

Market value

Market Cap11.91B USD

Today's price times the shares.

Value vs market

Margin of Safety+15.1%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 16.28B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF18.31B USD
+②Invested Capital at Year 15, Today8.85B USD
−③Net Debt Today10.88B USD
=Value16.28B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment rising to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

18.31B USD

②Invested Capital at Year 15, Today

8.85B USD

③Net Debt Today

10.88B USD

Market value

Market Cap11.91B USD

Today's price times the shares.

Value vs market

Margin of Safety+26.8%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 6.07%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.83×Market Risk Premium 6.00%= 9.47%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 377.43M USDPretax Income 1.78B USD= 21.22%

The tax the interest saves.

Interest Expense =EBIT 2.23B USD−Pretax Income 1.78B USD= 452.03M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 452.03M USDTotal Debt 12.53B USD×(1 − Tax Rate for WACC 21.22%)= 2.84%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 12.53B USDMarket Cap + Total Debt 11.91B USD + 12.53B USD= 51.27%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 48.73%×Cost of Equity 9.47%+Debt Weight 51.27%×Cost of Debt 2.84%= 6.07%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 35.78B USD − Total Liabilities 20.31B USD = Book Value Today 15.47B USD

Total Debt 12.53B USD − Cash and Short-Term Investments 1.66B USD = Net Debt Today 10.88B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-9.3%at most 5%passes266,109,685 / 293,413,449
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets5.6%at least -10.0%passes(3.15B USD − 1.15B USD) ÷ 35.78B USD
Price to bookMarket Cap ÷ Book Value Today0.77×at most 3×passes11.91B USD ÷ 15.47B USD
Operating marginOperating Income ÷ Revenue9.3%above 10.0%does not pass2.15B USD ÷ 23.08B USD
Revenue growthRevenue ÷ Revenue a Year Before − 114.6%above 10.0%passes23.08B USD / 20.14B USD
Net cash(Cash − Total Debt) ÷ Market Cap-95.0%above -30%does not pass(1.21B USD − 12.53B USD) ÷ 11.91B USD
Operating efficiencyOperating Income ÷ Gross Profit36.3%above 25.0%passes2.15B USD ÷ 5.91B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

40 USD

Enterprise value

21.47B USD

market cap plus net debt

EV / EBITDA

7.88×

Price / book

0.84×

the provider's book

Price / earnings

11.91×

Return on equity

8.5%

the provider's, not the engine's

Profit margin

4.8%

Revenue growth

1.4%

Analyst target, mean

42 USD

Analysts

17

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

20.70B21.55B20.14B23.08B

Gross profit

5.22B5.46B4.95B5.91B

Operating income

1.55B1.64B1.53B2.15B

EBITDA

operating income before depreciation and amortisation

3.65B3.56B3.34B3.99B

Pretax income

1.30B1.14B1.10B1.78B

Net income

718.62M552.85M560.32M1.15B

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

842.00M732.73M713.56M1.32B

R&D

243.97M257.01M191.14M185.76M
Balance sheet, year end

Total assets

38.15B37.59B34.96B36.46B

Total liabilities

21.67B21.17B18.54B19.66B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

14.93B15.09B15.18B15.65B

Total debt

14.08B13.35B11.44B12.69B

Cash and equivalents

1.36B1.53B1.20B1.86B

Net PP&E

fixed assets after depreciation

8.90B8.26B7.56B7.64B

Working capital

current assets less current liabilities

1.85B2.87B2.36B1.94B
Cash flow

Operating cash flow

2.31B2.91B2.49B3.15B

Capital expenditure

paid out, so below zero

-772.60M-758.48M-728.49M-1.08B

Depreciation and amortisation

1.96B1.94B1.81B1.76B

Free cash flow

operating cash flow plus capital expenditure

1.54B2.15B1.76B2.08B